Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 45

1.

Boosting Abscopal Response to Radiotherapy with Sargramostim: A Review of Data and Ongoing Studies.

Leary R, Gardner RB, Mockbee C, Roychowdhury DF.

Cureus. 2019 Mar 19;11(3):e4276. doi: 10.7759/cureus.4276. Review.

2.

Examining trends in the diversity of the U.S. National Institutes of Health participating and funded workforce.

Nikaj S, Roychowdhury D, Lund PK, Matthews M, Pearson K.

FASEB J. 2018 Jun 19:fj201800639. doi: 10.1096/fj.201800639. [Epub ahead of print]

PMID:
29920223
3.

Phase II Study of Crizotinib in East Asian Patients With ROS1-Positive Advanced Non-Small-Cell Lung Cancer.

Wu YL, Yang JC, Kim DW, Lu S, Zhou J, Seto T, Yang JJ, Yamamoto N, Ahn MJ, Takahashi T, Yamanaka T, Kemner A, Roychowdhury D, Paolini J, Usari T, Wilner KD, Goto K.

J Clin Oncol. 2018 May 10;36(14):1405-1411. doi: 10.1200/JCO.2017.75.5587. Epub 2018 Mar 29.

PMID:
29596029
4.

Etiological study of lymphadenopathy in HIV-infected patients in a tertiary care hospital.

Nag D, Dey S, Nandi A, Bandyopadhyay R, Roychowdhury D, Roy R.

J Cytol. 2016 Apr-Jun;33(2):66-70. doi: 10.4103/0970-9371.182518.

5.

How Criterion Scores Predict the Overall Impact Score and Funding Outcomes for National Institutes of Health Peer-Reviewed Applications.

Eblen MK, Wagner RM, RoyChowdhury D, Patel KC, Pearson K.

PLoS One. 2016 Jun 1;11(6):e0155060. doi: 10.1371/journal.pone.0155060. eCollection 2016.

6.

Clitoral Length and Anogenital Ratio in Indian Newborn Girls.

Mondal R, Chatterjee K, Samanta M, Hazra A, Ray S, Sabui TK, Banerjee B, Das S, Roychowdhury D, Biswas R.

Indian Pediatr. 2016 Apr;53(4):299-303.

7.

Size and characteristics of the biomedical research workforce associated with U.S. National Institutes of Health extramural grants.

Pool LR, Wagner RM, Scott LL, RoyChowdhury D, Berhane R, Wu C, Pearson K, Sutton JA, Schaffer WT.

FASEB J. 2016 Mar;30(3):1023-36. doi: 10.1096/fj.14-264358. Epub 2015 Dec 1.

8.

Phase II proof-of-concept study of pazopanib monotherapy in treatment-naive patients with stage I/II resectable non-small-cell lung cancer.

Altorki N, Lane ME, Bauer T, Lee PC, Guarino MJ, Pass H, Felip E, Peylan-Ramu N, Gurpide A, Grannis FW, Mitchell JD, Tachdjian S, Swann RS, Huff A, Roychowdhury DF, Reeves A, Ottesen LH, Yankelevitz DF.

J Clin Oncol. 2010 Jul 1;28(19):3131-7. doi: 10.1200/JCO.2009.23.9749. Epub 2010 Jun 1.

PMID:
20516450
9.

Pazopanib in locally advanced or metastatic renal cell carcinoma: results of a randomized phase III trial.

Sternberg CN, Davis ID, Mardiak J, Szczylik C, Lee E, Wagstaff J, Barrios CH, Salman P, Gladkov OA, Kavina A, Zarbá JJ, Chen M, McCann L, Pandite L, Roychowdhury DF, Hawkins RE.

J Clin Oncol. 2010 Feb 20;28(6):1061-8. doi: 10.1200/JCO.2009.23.9764. Epub 2010 Jan 25.

PMID:
20100962
10.

Effect of eltrombopag on platelet counts and bleeding during treatment of chronic idiopathic thrombocytopenic purpura: a randomised, double-blind, placebo-controlled trial.

Bussel JB, Provan D, Shamsi T, Cheng G, Psaila B, Kovaleva L, Salama A, Jenkins JM, Roychowdhury D, Mayer B, Stone N, Arning M.

Lancet. 2009 Feb 21;373(9664):641-8. doi: 10.1016/S0140-6736(09)60402-5.

PMID:
19231632
11.

Multicenter phase II study of lapatinib in patients with brain metastases from HER2-positive breast cancer.

Lin NU, Diéras V, Paul D, Lossignol D, Christodoulou C, Stemmler HJ, Roché H, Liu MC, Greil R, Ciruelos E, Loibl S, Gori S, Wardley A, Yardley D, Brufsky A, Blum JL, Rubin SD, Dharan B, Steplewski K, Zembryki D, Oliva C, Roychowdhury D, Paoletti P, Winer EP.

Clin Cancer Res. 2009 Feb 15;15(4):1452-9. doi: 10.1158/1078-0432.CCR-08-1080.

12.

A phase III randomized comparison of lapatinib plus capecitabine versus capecitabine alone in women with advanced breast cancer that has progressed on trastuzumab: updated efficacy and biomarker analyses.

Cameron D, Casey M, Press M, Lindquist D, Pienkowski T, Romieu CG, Chan S, Jagiello-Gruszfeld A, Kaufman B, Crown J, Chan A, Campone M, Viens P, Davidson N, Gorbounova V, Raats JI, Skarlos D, Newstat B, Roychowdhury D, Paoletti P, Oliva C, Rubin S, Stein S, Geyer CE.

Breast Cancer Res Treat. 2008 Dec;112(3):533-43. doi: 10.1007/s10549-007-9885-0. Epub 2008 Jan 11.

PMID:
18188694
13.

The value of label recommendations: how to dose lapatinib.

Koch KM, Beelen AP, Ho PT, Roychowdhury DF.

J Clin Oncol. 2007 Nov 20;25(33):5331-2; author reply 5334-5. No abstract available.

PMID:
18024883
14.

A phase II study of sequential neoadjuvant gemcitabine and paclitaxel, radiation therapy with cisplatin and 5-fluorouracil and surgery in locally advanced esophageal carcinoma.

Lowy AM, Firdaus I, Roychowdhury D, Redmond K, Howington JA, Sussman JJ, Safa M, Ahmad SA, Reed MF, Rose P, James L, Jazieh AR.

Am J Clin Oncol. 2006 Dec;29(6):555-61.

PMID:
17148991
15.

Polarization phase in aberration compensation.

Roychowdhury D, Bhattacharya K, Chakraborty AK.

Micron. 2007;38(2):158-64. Epub 2006 Jul 31.

PMID:
16950626
16.

Optimized sequence of drug administration and schedule leads to improved dose delivery for gemcitabine and paclitaxel in combination: a phase I trial in patients with recurrent ovarian cancer.

Poole CJ, Perren T, Gawande S, Ridderheim M, Cook J, Jenkins A, Roychowdhury D.

Int J Gynecol Cancer. 2006 Mar-Apr;16(2):507-14.

PMID:
16681719
17.

First-line gemcitabine versus epirubicin in postmenopausal women aged 60 or older with metastatic breast cancer: a multicenter, randomized, phase III study.

Feher O, Vodvarka P, Jassem J, Morack G, Advani SH, Khoo KS, Doval DC, Ermisch S, Roychowdhury D, Miller MA, von Minckwitz G.

Ann Oncol. 2005 Jun;16(6):899-908. Epub 2005 Apr 8.

PMID:
15821120
18.

Phase I trials: physician and patient perceptions.

Roychowdhury D.

J Clin Oncol. 2003 Dec 15;21(24):4658-9; author reply 4659-60. No abstract available.

PMID:
14673063
19.
20.

Health-related quality-of-life parameters as independent prognostic factors in advanced or metastatic bladder cancer.

Roychowdhury DF, Hayden A, Liepa AM.

J Clin Oncol. 2003 Feb 15;21(4):673-8.

PMID:
12586805
21.

Long-term survival in phase II trials of gemcitabine plus cisplatin for advanced transitional cell cancer.

Stadler WM, Hayden A, von der Maase H, Roychowdhury D, Dogliotti L, Seymour L, Kaufmann D, Moore M.

Urol Oncol. 2002 Jul-Aug;7(4):153-7.

PMID:
12474531
22.

A report on serious pulmonary toxicity associated with gemcitabine-based therapy.

Roychowdhury DF, Cassidy CA, Peterson P, Arning M.

Invest New Drugs. 2002 Aug;20(3):311-5.

PMID:
12201493
23.

Cisplatin, etoposide, and paclitaxel with granulocyte colony-stimulating factor in untreated patients with extensive-stage small cell lung cancer: a phase II trial of the Southwest Oncology Group.

Kelly K, Lovato L, Bunn PA Jr, Livingston RB, Zangmeister J, Taylor SA, Roychowdhury D, Crowley JJ, Gandara DR; Southwest Oncology Group.

Clin Cancer Res. 2001 Aug;7(8):2325-9.

24.

Incidence of thrombocytopenia with gemcitabine-based therapy and influence of dosing and schedule.

Cassidy CA, Peterson P, Cirera L, Roychowdhury DF.

Anticancer Drugs. 2001 Apr;12(4):383-5. No abstract available.

PMID:
11335796
25.

Venous thromboembolism and cancer.

Roychowdhury D.

N Engl J Med. 2000 Nov 2;343(18):1337-8. No abstract available.

PMID:
11183564
26.

Gemcitabine and cisplatin versus methotrexate, vinblastine, doxorubicin, and cisplatin in advanced or metastatic bladder cancer: results of a large, randomized, multinational, multicenter, phase III study.

von der Maase H, Hansen SW, Roberts JT, Dogliotti L, Oliver T, Moore MJ, Bodrogi I, Albers P, Knuth A, Lippert CM, Kerbrat P, Sanchez Rovira P, Wersall P, Cleall SP, Roychowdhury DF, Tomlin I, Visseren-Grul CM, Conte PF.

J Clin Oncol. 2000 Sep;18(17):3068-77.

PMID:
11001674
27.

Multilobated large B-cell lymphoma diagnosed cytologically. A case report.

Sheyn I, Mira J, Yassin R, Steele P, Roychowdhury D, Blanco R.

Acta Cytol. 1999 Sep-Oct;43(5):847-52.

PMID:
10518141
28.

Interferon alfa-2b and cytarabine in chronic myelogenous leukemia.

Patel T, Roychowdhury DF.

N Engl J Med. 1997 Nov 27;337(22):1634-5. No abstract available.

PMID:
9411231
29.
30.

New prognostic factors in nasopharyngeal carcinoma. Tumor angiogenesis and C-erbB2 expression.

Roychowdhury DF, Tseng A Jr, Fu KK, Weinburg V, Weidner N.

Cancer. 1996 Apr 15;77(8):1419-26.

PMID:
8608524
31.

Aspirin and the risk of colorectal cancer in women.

Roychowdhury DF.

N Engl J Med. 1996 Jan 11;334(2):120; author reply 121. No abstract available.

PMID:
8531950
32.
33.

Effects of acute administration of nifedipine on glomerular filtration rate and urinary excretion of sodium and uric acid in patients with mild-moderate essential hypertension.

Roychowdhury D, Padhy AK, Tiwari SC, Gupta K, Gopinath PG, Malhotra KK.

Indian J Physiol Pharmacol. 1988 Oct-Dec;32(4):278-84.

PMID:
3063659
34.

Gender identity disorder : a case report.

Banerjee G, Roychowdhury DP, Ghosh SS.

Indian J Psychiatry. 1987 Apr;29(2):171-3. No abstract available.

35.

Effect of diabetes mellitus on activities of some glycolytic, hexose monophosphate & other enzymes of erythrocytes of different ages.

Gandhi CR, Roychowdhury D.

Indian J Exp Biol. 1982 Apr;20(4):347-9. No abstract available.

PMID:
7183540
36.

Effect of prostaglandins A-1, E-2 and F-2 alpha on blood plasma levels of testosterone, LH and FSH in male rats.

Didolkar AK, Gurjar A, Joshi UM, Sheth AR, Roychowdhury D.

Andrologia. 1981 Jan-Feb;13(1):50-5.

PMID:
6789715
37.

Effect of aspirin on spermatogenesis in mature and immature rats.

Didolkar AK, Patel PB, Roychowdhury D.

Int J Androl. 1980 Oct;3(5):585-93.

PMID:
7440017
38.

Effects of aspirin on blood plasma levels of testosterone, LH and FSH in maturing male rats.

Didolkar AK, Gurjar A, Joshi UM, Sheth AR, Roychowdhury D.

Int J Androl. 1980 Jun;3(3):312-8.

PMID:
6773893
39.

Effects of prostaglandins E-1, E-2, F-1a and F-2a on human sperm motility.

Didolkar AK, Roychowdhury D.

Andrologia. 1980 Mar-Apr;12(2):135-40.

PMID:
6446248
40.

Effect of prostaglandins A-1, E-2 and F-2 alpha on spermatogenesis in rats.

Didolkar AK, Roychowdhury D.

J Reprod Fertil. 1980 Jan;58(1):275-8.

PMID:
7359486
41.

Effect of unilateral visual deprivation on the activities of acetylcholinesterase, cholinesterase and carbonic anhydrase of the optic lobe of pigeon.

Chakrabarti T, Dias PD, Roychowdhury D, Daginawala HF.

J Neurochem. 1974 May;22(5):865-7. No abstract available.

PMID:
4209870
42.

Studies on urticaria pigmentosa.

Roychowdhury DS, Banerjee AK.

Bull Calcutta Sch Trop Med. 1971 Apr;19(2):39-40. No abstract available.

PMID:
4144296
43.

Progressive alopecia associated with dry scalp: preliminary observations.

Banerjee AK, Roychowdhury DS.

Bull Calcutta Sch Trop Med. 1970 Jan;18(1):18 passim. No abstract available.

PMID:
5519123
44.

Treatment of infective warts with small-pox vaccine--a preliminary report.

Roychowdhury DS, Roy S, Banerjee AK.

Bull Calcutta Sch Trop Med. 1969 Oct;17(4):115-6. No abstract available.

PMID:
5401904
45.

Pyaemic ulcers.

Roychowdhury DS.

J Indian Med Assoc. 1965 Dec 1;45(11):614-6. No abstract available.

PMID:
5842653

Supplemental Content

Loading ...
Support Center